September 26, 2025 3:13 PM
Industry expert says India unlikely to be impacted by US pharma tariffs
India's pharmaceutical exports are not expected to face a major impact following the recent announcement of a 100 per cent tariff on branded and patented pharmaceutical products by the US, Sudarshan Jain, General Secretary of the Indian Pharmaceutical Alliance (IPA), said on Friday. Speaking to ANI, Jain said that India's exports to the US primarily consist of generic drugs and active pharmaceutical ingredients (APIs), which are not covered under this tariff. "This [100 per cent tariff on impo...